Astellas Pharma Inc. v Comptroller General of Patents

Core Citations

CONSIDERS

• Takeda Chemicals Ltd v Comptroller General of the Patent Office
• Patents Act 1977 - Articles : S-125
• Patents Act 1977 - Articles : S-21

CITES

• Generics (UK) Ltd v Daiichi Pharmaceutical Company Ltd (Costs)
• Takeda Chemicals Ltd v Comptroller General of the Patent Office

REFERS TO

• Edwards (A.C.) Ltd v Acme Signs & Displays Ltd
• Gilead Sciences Inc. v UK Intellectual Property Office

CONSIDERS

• Takeda Chemicals Ltd v Comptroller General of the Patent Office

REPORTED OPINION OF in

• [2009] 110 BMLR 148

CONSIDERED in

• Medeva BV v The Comptroller General of Patents
• Medeva BV v Comptroller General of Patents
• Medimmune Ltd v Novartis Pharmaceuticals UK Ltd and Another

REFERRED in

• Medeva BV v The Comptroller General of Patents

This document cites

• Takeda Chemicals Ltd v Comptroller General of the Patent Office
• Generics (UK) Ltd v Daiichi Pharmaceutical Company Ltd (Costs)
• Takeda Chemicals Ltd v Comptroller General of the Patent Office
• Edwards (A.C.) Ltd v Acme Signs & Displays Ltd
• Gilead Sciences Inc. v UK Intellectual Property Office



See all quotations

• Takeda Chemicals Ltd v Comptroller General of the Patent Office
• Patents Act 1977
• Farmitalia Carlo Erba Srl.
• Council Regulation (EEC) No 1768/92 of 18 June 1992 concerning the creation of a supplementary protection certificate for medicinal products
• Council Directive 65/65/EEC of 26 January 1965 on the approximation of provisions laid down by Law, Regulation or Administrative Action relating to proprietary medicinal products
• Council Directive 81/851/EEC of 28 September 1981 on the approximation of the laws of the Member States relating to veterinary medicinal products